CENTENE CORP
CNCAPI behind this page
CNC Q3 2025 request
Playground key active
/api/financials?ticker=CNC&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue | 44,898 | 36,899 | +21.7% |
Show Product Lines breakouts |
|||
| Health Care Premium | 44,126 | 36,115 | +22.2% |
| Health Care Premium · All Other Segments | 598 | 488 | +22.5% |
| Health Care Premium · Commercial | 10,991 | 8,693 | +26.4% |
| Health Care Premium · Medicaid | 23,146 | 21,291 | +8.7% |
| Health Care Premium · Medicare | 9,391 | 5,643 | +66.4% |
| Premium and service revenues | 44,898 | 36,899 | +21.7% |
| Premium and service revenues · All Other Segments | 1,344 | 1,247 | +7.8% |
| Premium and service revenues · Commercial | 10,992 | 8,693 | +26.4% |
| Premium and service revenues · Medicaid | 23,171 | 21,316 | +8.7% |
| Premium and service revenues · Medicare | 9,391 | 5,643 | +66.4% |
| Service | 772 | 784 | -1.5% |
| Service · All Other Segments | 746 | 759 | -1.7% |
| Service · Commercial | 1 | — | — |
| Service · Medicaid | 25 | 25 | 0.0% |
| Premium Tax Revenue | 4,792 | 5,124 | -6.5% |
Show Business Segments breakouts |
|||
| Medicaid · Operating Segments | 4,792 | 5,124 | -6.5% |
| Revenue | 49,690 | 42,023 | +18.2% |
Show Business Segments breakouts |
|||
| All Other Segments | 1,344 | 1,247 | +7.8% |
| All Other Segments · Intersegment Elimination | -4,194 | -4,290 | +2.2% |
| All Other Segments · Operating Segments | 4,194 | 4,290 | -2.2% |
| Commercial | 10,992 | 8,693 | +26.4% |
| Medicaid | 27,963 | 26,440 | +5.8% |
| Medicare | 9,391 | 5,643 | +66.4% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -4,194 | -4,290 | +2.2% |
| Operating Segments | 4,194 | 4,290 | -2.2% |
| Policyholder Benefits And Claims Incurred Net | 40,902 | 32,201 | +27.0% |
Show Business Segments breakouts |
|||
| All Other Segments | 559 | 458 | +22.1% |
| Commercial | 9,876 | 6,957 | +42.0% |
| Medicaid | 21,614 | 19,818 | +9.1% |
| Medicare | 8,853 | 4,968 | +78.2% |
| Cost of Revenue | 651 | 692 | -5.9% |
Show Business Segments breakouts |
|||
| All Other Segments | 626 | 669 | -6.4% |
| Medicaid | 25 | 23 | +8.7% |
| Selling, General & Administrative | 3,145 | 3,057 | +2.9% |
| Depreciation | 147 | 140 | +5.0% |
| Amortization Of Intangible Assets | 170 | 173 | -1.7% |
| Premium Tax Expense | 4,886 | 5,095 | -4.1% |
| Asset Impairment Charges | 6,743 | — | — |
| Total Costs & Expenses | 56,644 | 41,358 | +37.0% |
| Operating Income | -6,954 | 665 | -1145.7% |
| Investment Income Nonoperating | 450 | 432 | +4.2% |
| Interest Expense | -170 | -176 | +3.4% |
| Income Before Taxes | -6,674 | 921 | -824.6% |
| Income Tax Expense (Benefit) | -42 | 211 | -119.9% |
| Net Income | -6,632 | 710 | -1034.1% |
| Net Income Loss Attributable To Noncontrolling Interest | 1 | 3 | -66.7% |
| Net Income | -6,631 | 713 | -1030.0% |
| EPS (Basic) | -13.5 | 1.37 | -1085.4% |
| EPS (Diluted) | -13.5 | 1.36 | -1092.6% |
| Wtd Avg Shares (Basic) | 491,141 | 521,965 | -5.9% |
| Wtd Avg Shares (Diluted) | 491,141 | 523,542 | -6.2% |
| Gross Profit | 3,345 | 4,006 | -16.5% |
Show Business Segments breakouts |
|||
| All Other Segments | 159 | 120 | +32.5% |
| Commercial | 1,116 | 1,736 | -35.7% |
| Medicaid | 1,532 | 1,475 | +3.9% |
| Medicare | 538 | 675 | -20.3% |
| Other Non-Operating Income (Expense) | 280 | 256 | +9.4% |
| Comprehensive Income | -6,500 | 1,133 | -673.7% |
| Revenue From Contract With Customer Including Assessed Tax | 49,690 | 42,023 | +18.2% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 1,344 | 1,247 | +7.8% |
| Commercial · Operating Segments | 10,992 | 8,693 | +26.4% |
| Medicaid · Operating Segments | 27,963 | 26,440 | +5.8% |
| Medicare · Operating Segments | 9,391 | 5,643 | +66.4% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 17,058 | 14,577 | +17.0% |
| Premiums And Other Receivables Net | 23,109 | 18,281 | +26.4% |
| Short-Term Investments | 2,179 | 2,992 | -27.2% |
| Other Assets Current | 1,716 | 1,559 | +10.1% |
| Total Current Assets | 44,062 | 37,409 | +17.8% |
| Non-Current Assets | |||
| Long Term Investments | 18,180 | 17,691 | +2.8% |
| Other Restricted Assets Noncurrent | 1,416 | 1,452 | -2.5% |
| Property, Plant & Equipment | 2,161 | 2,042 | +5.8% |
| Goodwill | 10,835 | — | — |
Show Business Segments breakouts |
|||
| All Other Segments | 19 | — | — |
| Commercial | 5,212 | — | — |
| Medicaid | 4,012 | — | — |
| Medicare | 1,592 | — | — |
| Other Non-Current Assets | 593 | 617 | -3.9% |
| Total Assets | 82,087 | 82,351 | -0.3% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 4,840 | 5,582 | -13.3% |
| Current Liabilities | |||
| Liability For Claims And Claims Adjustment Expense | 21,493 | 17,995 | +19.4% |
Show Business Segments breakouts |
|||
| All Other Segments | 174 | 177 | -1.7% |
| Commercial | 5,628 | 4,067 | +38.4% |
| Medicaid | 11,343 | 10,168 | +11.6% |
| Medicare | 4,348 | 3,583 | +21.4% |
| Accounts Payable And Accrued Liabilities Current | 16,875 | 13,338 | +26.5% |
| Returnof Premium Payable | 1,568 | 1,959 | -20.0% |
| Deferred Revenue (Current) | 656 | 658 | -0.3% |
| Current Portion of Long-Term Debt | 38 | 111 | -65.8% |
| Total Current Liabilities | 40,630 | 34,061 | +19.3% |
| Non-Current Liabilities | |||
| Long-Term Debt | 17,545 | 17,494 | +0.3% |
| Deferred Tax Liabilities | 810 | 769 | +5.3% |
| Other Non-Current Liabilities | 2,047 | 2,618 | -21.8% |
| Total Liabilities | 61,032 | 54,942 | +11.1% |
| Other Liabilities | |||
| Redeemable Noncontrolling Interest Equity Carrying Amount | 23 | 13 | +76.9% |
| Stockholders' Equity | |||
| Common Stock | 1 | 1 | 0.0% |
| Additional Paid In Capital Common Stock | 20,713 | 20,522 | +0.9% |
| Accumulated Other Comprehensive Income | -100 | -226 | +55.8% |
| Retained Earnings | 9,775 | 15,065 | -35.1% |
| Treasury Stock Common Value | -9,441 | -8,055 | -17.2% |
| Total Stockholders' Equity | 20,948 | 27,307 | -23.3% |
| Minority Interest | 84 | 89 | -5.6% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 21,032 | 27,396 | -23.2% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -100 | -226 | +55.8% |
| Additional Paid In Capital | 20,713 | 20,522 | +0.9% |
| Common Stock | 1 | 1 | 0.0% |
| Noncontrolling Interest | 84 | 89 | -5.6% |
| Retained Earnings | 9,775 | 15,065 | -35.1% |
| Treasury Stock Common | -9,441 | -8,055 | -17.2% |
| Total Liabilities & Equity | 82,087 | 82,351 | -0.3% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation And Amortization | 946 | 927 | +2.0% |
| Stock-Based Compensation | 146 | 181 | -19.3% |
| Deferred Income Taxes | 13 | 14 | -7.1% |
| Gain Loss On Sale Of Business | 10 | -103 | +109.7% |
| Increase Decrease In Premiums Receivable | -3,338 | -2,737 | -22.0% |
| Increase Decrease In Other Operating Assets | -245 | 78 | -414.1% |
| Increase Decrease In Health Care Insurance Liabilities | 3,176 | -5 | +63620.0% |
| Change in Deferred Revenue | -5 | -58 | +91.4% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 2,681 | -503 | +633.0% |
| Change in Other Liabilities | 38 | -84 | +145.2% |
| Other Operating Activities Cash Flow Statement | 8 | 4 | +100.0% |
| Net Cash from Operations | 4,651 | 741 | +527.7% |
| Investing Activities | |||
| Capital Expenditures | -554 | -490 | -13.1% |
| Payments To Acquire Investments | -3,765 | -5,770 | +34.7% |
| Proceeds From Sale Maturity And Collections Of Investments | 4,131 | 4,147 | -0.4% |
| Net Cash from Investing | -188 | -1,154 | +83.7% |
| Financing Activities | |||
| Proceeds From Issuance Of Long Term Debt | 750 | 350 | +114.3% |
| Repayments Of Long Term Debt | -1,708 | -594 | -187.5% |
| Share Repurchases | -473 | -2,181 | +78.3% |
| Proceeds From Issuance Of Common Stock | 29 | 37 | -21.6% |
| Payments To Minority Shareholders | -19 | — | — |
| Proceeds From Payments For Other Financing Activities | -13 | -5 | -160.0% |
| Net Cash from Financing | -1,434 | -2,393 | +40.1% |
| Supplemental | |||
| Interest Paid | 458 | 495 | -7.5% |
| Income Taxes Paid | 540 | 821 | -34.2% |
| Other Cash Flow | |||
| Net Change in Cash | 3,029 | -2,799 | +208.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 17,185 | 14,650 | +17.3% |
| Restricted Cash And Cash Equivalents | 127 | 73 | +74.0% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.